Columnists
Ontario government official announce partnership with the federal government, city of Toronto and Sanofi to expand domestic vaccine manufacturing capacity. Image credit: Premier of Ontario Photography/Flickr
Linda McQuaig | The pandemic has only increased the clout of the powerful drug industry, which largely controls access to COVID vaccines desperately needed by Canadians and others.
Columnists
Vaccine clinic signs. Image credit: Joshua Hoehne/Unsplash
Rick Salutin | The giddiness people express after getting their first jab came unexpectedly. It's a pandemic of public delight, the way people burst onto a dance floor from the sidelines.
Columnists
Vaccine vial. Image credit: Premier of Ontario Photography/Flickr
Linda McQuaig | The precariousness of the global vaccine supply points to how immoral it is that the pharmaceutical industry has such sweeping life-and-death power, even in the midst of a catastrophic pandemic.
Podcast
Jason MacLean
Marc Belanger, C. Marie Ainsborough, Derek Blackadder | RadioLabour's Canada report April 5-12, 2019 -- health care in Nova Scotia is in a crisis, corporate lobbyists are fighting pharmacare, and more.
Podcast
Matt Embry and Spotlight Productions. Used with permission.
David Peck | Matt and Face2Face host David Peck talk the film 'Living Proof', about the medical community, multiple sclerosis, science and alternative approaches to health, activism and patient-funded research.
Blog
Mortar and pestle with pills. Photo: Pixabay
Ed Finn | Medicare originated at the provincial, not federal level -- in Saskatchewan. So could the extension of public health care to include prescription drugs, and even dental and vision coverage.
Blog
Image: Twitter/Canada 2020
Michael Butler | One of the sponsors listed is the largest pharmaceutical lobby group in the U.S.
Blog
Image: Flickr/Konstantin Lazorkin
Michael Butler | Do you think your pension plans should invest in companies that jack up the price of drugs for seniors and the suffering?
Blog
Michael Butler | Big Pharma influences what doctors prescribe -- a practice that needs to change.
Blog
Michael Butler | The TPP prohibits governments from requiring information about drug prices or R&D costs in connection with registration. Who wants to enforce a further lack of knowledge of drug prices or R&D costs?
Blog
Michael Butler | Health Canada finally acknowledged what health economists, academics and activists had been saying for some time: drug costs will rise under pending trade deals like the TPP.
Blog
Image: Bill Brooks/flickr
Scott Sinclair | The release of the final Trans-Pacific Partnership text shows that the trade deal has worrying implications for Canada, binding our country to a regulatory regime that would lock in high drug costs.